Paricalcitol For CKD-MBD Associated With Secondary Hyperparathyroidism: A Case Series Focus On TRAP5b, b-ALP, and DKK-1

Budi Suprapti, Frenky Hartono, Muhammad Iqbal, Muhammad Isnaini Zuhri, Aditiawardana Aditiawardana


Chronic kidney disease (CKD) lead to secondary hyperparathyroidism (sHPT) that caused by phosphate retention and hypocalcemia. This condition known as mineral and bone disorder (CKD-MBD). The increase in parathyroid hormone would increase bone turnover that result in an increased risk of bone fractures, and vascular calcification. These will increase the levels of tartrate-resistant acid phosphatase 5b (TRAP5b), and bone-specific alkaline phosphatase (b-ALP), which is a marker of bone turnover, and also dickkopf-related protein 1 (DKK-1), which is an inhibitor of the Wnt pathway. Secondary hyperparathyroidism in CKD also caused by calcitriol deficiency. Paricalcitol is a synthetic calcitrol analogue used to reduce parathyroid hormone (iPTH) with minimal calcemic and phosphatemic activity. Vitamin D receptor activation by paricalcitol will decrease TRAP5b, b-ALP, and DKK-1. In this study we reported 9 cases of CKD-MBD with Hemodialysis (HD) and associated with sHPT. Four of nine cases received 5μg paricalcitol every HD (twice a week) while the others five is not. Level of iPTH, phosphate, calcium, TRAP5b, b-ALP, and DKK-1 were measured before initiation of study and after three months treatment. According to this study, the paricalcol administration suppresses the increase in iPTH level, bone turnover and vascular calcification showed by decreasing or supresses the increase b-ALP, TRAP5b, DKK-1  leves without increasing calcium and phosphate levels.

Full Text:



Bandyopadhyay A., Wang L., Agyin J., Tang Y., Lin S., Yeh I., De K., and Sun L. 2010. Doxorubicin in combination with a small TGFβ inhibitor: a potential novel therapy for metastatic breast cancer in mouse models. Plos One, 5(4):e10365.

Bapsy PP., and Sahoo TP. 2004. Recent advances in the management of metastatic breast cancer, Indian Journal of Medical & Paediatric Oncology, 24 (2):19-26.

Chen M., Chen R., Wang S., Tan W., Hu Y., Peng X., and Wang Y. 2013. Chemical components, pharmacological properties, and nanoparticulate delivery systems of Brucea javanica, Int. J. nanomedicine, 8. 85-92. 10.2147/IJN.S31636.

Choi MA., Kim SH., Chung WY., Hwang JK., and Park KK. 2005. Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model, Biochem. Biophys. Res. Commun., 326(1):210-7.

Engeland M., Nieland LJW., Ramaekers FCS., Schutte B., and Reutelingsperger CPM. 1998. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure, Cytometry, 31:1-9.

Kim J., Lau EK., Pan L., and De Blanco EJC. 2010. NFB inhibitors from Brucea javanica exhibiting intracellular effect on reactive oxygen species, Anticancer res., 30: 3295-3300.

Krstic J., and Santibanez JF. 2014. Transforming growth factor-beta and matrix metalloproteinases: functional interaction in tumor stroma-infiltrating myeloid cells, The Scientific World Journal, 2014: 521754.

Kunnumakkara AB., Anand P., and Aggarwal B. 2008. Curcumin inhibits proliferation, invasion, angiogenesis & metastasis of different cancers through interaction with multiple cell signalling proteins, Cancer Letter 269: 199-225.

Kupai K. 2011. Gelatin zymography for detection of matrix-metalloproteinase-2 and -9 (mmp-2, mmp-9) from myocardial samples, Practical course: Basic biochemical methods and ischemic heart model (link:

Lewandowska U., Gorlach S., Owczarek K., Hrabec E., Szewczyk K. 2014. Synergistic interaction between anticancer chemotherapeutics and phenolic compounds and anticancer synergy between polyphenols, Postepy Hig Med Dosw (online), (68):528-540.

Liang C., Park AY., and Guan J. 2007. In vitro scratch assay: a convenient & inexpensive method for analysis of cell migration in vitro, Nature Protocol, 2 (2). Doi:10.1038/nprot.2007.30.

Lin HJ., Su CC., Lu HF., Yang JS., Hsu SC., and Ip SW. 2010. Curcumin blocks migration & invasion of mouse-rat hybrid retina ganglion cells (n 18) through the inhibition of MMP-2, -9, PAK, Rho A & Rock-1 Gene expression, Oncology Reports, 23: 665-670 DOI: 10.3892/or_00000682.

Mandhare AA., Dhulap SA., Dhulap AS., and Biradar SC. 2015. Review on the Anticancer and In-silico Binding Studies of Phenanthroindolizidine Alkaloids, ImedPub journal, Vol 1 No 1:5.

Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, Journal of Immunological Methods, 65: 55-63.

Nan Z., Li YH., Wu XK., Wang GY., Cai DY., and Han FJ. 2015. Effect of Brucea javanica fruit oil emulsion combined cisplatin on the growth inhibition of transplanted tumor in human ovarian cancer SKOV3 nude mice: an experimental study. Zhongguo Zhong Xi Yi Jie He Za Zhi, 35 (1): 57-62.

Nie YL., Liy KX., Mao XY., Li YL, Li J., and Zhang MM. 2012. Effect of injection of Brucea javanica oil emulsion plus chemoradiotherapy for lung cancer: a review of clinical evidence, J Evid Based Med., 5(4):216-25.

Pratama RH., Ikhtiarsyah YG., Fitriasari A., Anindyajati Ikawati M., Meiyanto E. 2011. Awar-awar leaves ethanolic extract synergistically enhances cytotoxic of doxorubicin on T47D breast cancer cells, Ind J Pharm Sci., 9(1):67–71.

Reynolds CP., and Maurer BJ. 2005. Evaluating response to antineoplastic drug combinations in tissue culture models, Methods Mol Med., 110:173-83.

Sarkar FH., and Li Y. 2006. Using Chemopreventive agents to enhance the efficacy of cancer therapy, Cancer Rev., 66(7):3347-3350.

Sekti DA., Mubarok MF., Armandani I., Junedy S., and Meiyanto E. 2010. Awar-awar (Ficus septica Burm. F.) leaves ethanolic extract induced apoptosis of MCF-7 cells by downregulation of Bcl-2, J Trad Med., 15(3):100–104.

Smith LA., Cornelius VR., Plummer CJ., Levitt G., Verill M., Canney P., and Jones A. 2010. Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic Review & Meta-analysis of Randomised. BMC Cancer, 10:337.

Sugimoto K., Tamayose K., Sasaki M., Hayashi K., and Oshimi K. 2002. Low-dose doxorubicin-induced necrosis in Jurkat cells and its acceleration & conversion to apoptosis by antioxidants, British Journal of Haematology, 118:229-238. DOI: 10.1046/j.1365-2141.2002.03577.

Sugiyama T., and Sadzuka Y. 1999. Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma, Clin. Cancer Res., 5, 413–416.

Sutejo IR. 2015. Potensi Antimetastasis Kombinasi Ekstrak Etanolik Temulawak (Curcuma xanthorrhiza), Buah Makassar (Brucea javanica) dan Doxorubicin pada Sel 4T1, Thesis, Gadjah Mada University.

Tao K., Fang M., Alroy J., and Sahagian GG. 2008. Imagable 4T1 model for the study of late-stage breast cancer, BMC Cancer, 8:228.

Thangapazham RL., Sharma A., and Maheshwari RK. 2006. Multiple molecular targets in cancer chemoprevention by curcumin, The AAPS Journal, 8: E443.

Xinjie DU., and Linyi HE. 2013. The study on the expression effects of Brucea Javanica oil on VEGF and bFGF in proliferative endometrium hyperplasia of rats, Journal of Binzhou Medical University, 2013-01.



  • There are currently no refbacks.

Copyright (c) 2019 Indonesian Journal of Pharmacy

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:

analytics View My Stats